GlobalData
ReportStore
 

Home
Industry Reports
Pharmaceuticals and Healthcare

 
Single User License: 
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Buy Now Add to Cart
$2,000.00
Site License: 
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Buy Now Add to Cart
$4,000.00
Global License: 
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Buy Now Add to Cart
$6,000.00
Tab
Description
Table of Contents
List of Figures
List of Tables
Request Sample Pages
Send To Friend
Inquire Before Buying
 

Venous Thromboembolism - Drug Pipeline Analysis and Market Forecasts to 2016

Published: Feb-2010   Report Code: GDHCPRT057
Report Format: Electronic PDF
 
GlobalData, the industry analysis specialist’s new report, “Venous Thromboembolism – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global venous thromboembolism (VTE) market. The report identifies the key trends shaping and driving the global VTE market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shifts in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight into the pipeline products within the global VTE sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts

Scope

  • The scope of the report includes:
  • Annualized global VTE market revenues data from 2001 to 2009, forecast forward for seven years to 2016.
  • Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France and Japan.
  • Pipeline analysis data providing a split across different phases by the mechanism of action being developed and the emerging trends. Key classes of mechanism of action include vitamin K antagonists, tissue plasminogen activators and enzymes, direct thrombin inhibitors, and clotting-factor inhibitors or drugs that potentiate the action of antithrombin.
  • Analysis of the current and future market competition in the global VTE market. Key market players covered are Daiichi Sankyo Co.Ltd, Sanofi-aventis, Bristol-Myers Squibb, Novartis AG, GlaxoSmithKline, Astellas Pharma Inc, Pfizer Inc. Bayer and Johnson & Johnson.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for the future market associated with VTE.

Reasons to Buy

  • The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
  • Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global VTE market.
  • Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global VTE market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain the competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What is the next big thing in the global VTE market landscape? Identify, understand and capitalize.